Back to Authors

Brown, Mark J. F.

https://orcid.org/0000-0002-8887-3628

Mayo Clinic

St. Luke's Hospital

Citations 2

Imaging of Fontan-Associated Liver Disease
Brown, Mark J. F. , Kolbe, Amy B. , Hull, Nathan C. , Hilscher, Moira , Kamath, Patrick S. , Yalon, Mariana , Gu, Chris N., Amawi, Ali Dean Tahboub , Wells, Michael , Brown, Mark J., Venkatesh, Sudhakar K.

Journal of Computer Assisted Tomography | August 14, 2023 | Volume: 48 | Issue: 1 | Pages: 1-11

10.1097/rct.0000000000001533 Get It

Abstract The Fontan procedure is the definitive treatment for patients with single-ventricle physiology. Surgical advances have led to a growing number of patients surviving into adulthood. Fontan-associated liver disease (FALD) encompasses a spectrum of pathologic liver changes that occur secondary to altered physiology including congestion, fibrosis, and the development of liver masses. Assessment of FALD is difficult and relies on using imaging alongside of clinical, laboratory, and pathology information. Ultrasound, computed tomography, and magnetic resonance imaging are capable of demonstrating physiologic and hepatic parenchymal abnormalities commonly seen in FALD. Several novel imaging techniques including magnetic resonance elastography are under study for use as biomarkers for FALD progression. Imaging has a central role in detection and characterization of liver masses as benign or malignant. Benign FNH-like masses are commonly encountered; however, these can display atypical features and be mistaken for hepatocellular carcinoma (HCC). Fontan patients are at elevated risk for HCC, which is a feared complication and has a poor prognosis in this population. While imaging screening for HCC is widely advocated, no consensus has been reached regarding an optimal surveillance regimen.
Colonic Epithelial Circadian Disruption Worsens Dextran Sulfate Sodium–Induced Colitis
Jochum, Sarah B. , Shaikh, Maliha, Wilber, Sherry , Raeisi, Shohreh , Zhang, Lijuan , Song, Shiwen , Sanzo, Gabriella, Chouhan, Vijit , Ko, Frank C. , Post, Zoë , Tran, Laura , Ramirez, Vivian, Khazaie, Khashayarsha , Hayden, Dana M. , Brown, Mark J. F. , Voigt, Robin M. , Forsyth, Christopher B. , Swanson, Garth , Post, Zoe , Swanson, Garth R , Engen, Phillip A. , Naqib, Ankur D , Green, Stefan J. , Brown, Mark J, Keshavarzian, Ali

Inflammatory Bowel Diseases | October 26, 2022 | Volume: 29 | Issue: 3 | Pages: 444-457

10.1093/ibd/izac219 Get It

AbstractBackgroundDisruption of central circadian rhythms likely mediated by changes in microbiota and a decrease in gut-derived metabolites like short chain fatty acids (SCFAs) negatively impacts colonic barrier homeostasis. We aimed to explore the effects of isolated peripheral colonic circadian disruption on the colonic barrier in a mouse model of colitis and explore the mechanisms, including intestinal microbiota community structure and function.MethodsColon epithelial cell circadian rhythms were conditionally genetically disrupted in mice: TS4Cre-BMAL1lox (cBMAL1KO) with TS4Cre as control animals. Colitis was induced through 5 days of 2% dextran sulfate sodium (DSS). Disease activity index and intestinal barrier were assessed, as were fecal microbiota and metabolites.ResultsColitis symptoms were worse in mice with peripheral circadian disruption (cBMAL1KO). Specifically, the disease activity index and intestinal permeability were significantly higher in circadian-disrupted mice compared with control animals (TS4Cre) (P < .05). The worsening of colitis appears to be mediated, in part, through JAK (Janus kinase)-mediated STAT3 (signal transducer and activator of transcription 3), which was significantly elevated in circadian-disrupted (cBMAL1KO) mice treated with DSS (P < .05). Circadian-disrupted (cBMAL1KO) mice also had decreased SCFA metabolite concentrations and decreased relative abundances of SCFA-producing bacteria in their stool when compared with control animals (TS4Cre).ConclusionsDisruption of intestinal circadian rhythms in colonic epithelial cells promoted more severe colitis, increased inflammatory mediators (STAT3 [signal transducer and activator of transcription 3]), and decreased gut microbiota–derived SCFAs compared with DSS alone. Further investigation elucidating the molecular mechanisms behind these findings could provide novel circadian directed targets and strategies in the treatment of inflammatory bowel disease.